Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myocardial structural and functional changes in cardiac amyloidosis: insights from a prospective observational patient registry.
Duca F, Rettl R, Kronberger C, Binder C, Mann C, Dusik F, Schrutka L, Dalos D, Öztürk B, Dachs TM, Cherouny B, Camuz Ligios L, Agis H, Kain R, Koschutnik M, Donà C, Badr-Eslam R, Kastner J, Beitzke D, Loewe C, Nitsche C, Hengstenberg C, Kammerlander AA, Bonderman D. Duca F, et al. Among authors: camuz ligios l. Eur Heart J Cardiovasc Imaging. 2023 Dec 21;25(1):95-104. doi: 10.1093/ehjci/jead188. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37549339 Free PMC article.
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
Rettl R, Wollenweber T, Duca F, Binder C, Cherouny B, Dachs TM, Camuz Ligios L, Schrutka L, Dalos D, Beitzke D, Loewe C, Badr Eslam R, Kastner J, Hacker M, Bonderman D. Rettl R, et al. Among authors: camuz ligios l. Eur Heart J Cardiovasc Imaging. 2023 Jul 24;24(8):1019-1030. doi: 10.1093/ehjci/jead030. Eur Heart J Cardiovasc Imaging. 2023. PMID: 36881774 Free PMC article.
Hemodynamic Profiles and Their Prognostic Relevance in Cardiac Amyloidosis.
Duca F, Snidat A, Binder C, Rettl R, Dachs TM, Seirer B, Camuz-Ligios L, Dusik F, Capelle CDJ, Hong Q, Agis H, Kain R, Mascherbauer J, Hengstenberg C, Badr Eslam R, Bonderman D. Duca F, et al. Among authors: camuz ligios l. J Clin Med. 2020 Apr 11;9(4):1093. doi: 10.3390/jcm9041093. J Clin Med. 2020. PMID: 32290508 Free PMC article.
Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis.
Binder C, Duca F, Binder T, Rettl R, Dachs TM, Seirer B, Camuz Ligios L, Dusik F, Capelle C, Qin H, Agis H, Kain R, Hengstenberg C, Badr Eslam R, Bonderman D. Binder C, et al. Among authors: camuz ligios l. Clin Res Cardiol. 2021 Apr;110(4):532-543. doi: 10.1007/s00392-020-01698-7. Epub 2020 Sep 10. Clin Res Cardiol. 2021. PMID: 32914241 Free PMC article.
What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction.
Rettl R, Dachs TM, Duca F, Binder C, Dusik F, Seirer B, Schönauer J, Kronberger C, Camuz Ligios L, Hengstenberg C, Derkits N, Kastner J, Badr Eslam R, Bonderman D. Rettl R, et al. Among authors: camuz ligios l. J Clin Med. 2020 Nov 15;9(11):3669. doi: 10.3390/jcm9113669. J Clin Med. 2020. PMID: 33203151 Free PMC article.
Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy.
Badr Eslam R, Öztürk B, Rettl R, Capelle CDJ, Qin H, Binder C, Dachs TM, Camuz Ligios L, Duca F, Dalos D, Schrutka L, Alasti F, Kastner J, Vila G, Bonderman D. Badr Eslam R, et al. Among authors: camuz ligios l. Circ Heart Fail. 2022 Jul;15(7):e008381. doi: 10.1161/CIRCHEARTFAILURE.121.008381. Epub 2022 Jun 29. Circ Heart Fail. 2022. PMID: 35766028
Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy.
Rettl R, Duca F, Binder C, Dachs TM, Cherouny B, Camuz Ligios L, Mann C, Schrutka L, Dalos D, Charwat-Resl S, Badr Eslam R, Kastner J, Bonderman D. Rettl R, et al. Among authors: camuz ligios l. Amyloid. 2023 Mar;30(1):127-137. doi: 10.1080/13506129.2022.2131385. Epub 2022 Oct 17. Amyloid. 2023. PMID: 36251806
Cardiac amyloidosis: a significant blind spot of the H2FPEF score.
Duca F, Rettl R, Binder C, Dusik F, Schrutka L, Dalos D, Öztürk B, Capelle CD, Qin H, Dachs TM, Camuz Ligios L, Agis H, Kain R, Hengstenberg C, Badr-Eslam R, Kastner J, Bonderman D. Duca F, et al. Among authors: camuz ligios l. Panminerva Med. 2023 Dec;65(4):491-498. doi: 10.23736/S0031-0808.22.04649-3. Epub 2023 Feb 15. Panminerva Med. 2023. PMID: 36789997 Free article.
Exercise capacity assessed with the one-minute sit-to-stand test (1-min STST) and echocardiographic findings in patients with heart failure with preserved ejection fraction (HFpEF).
Kronberger C, Mousavi RA, Öztürk B, Dachs TM, Rettl R, Camuz-Ligios L, Litschauer B, Badr-Eslam R. Kronberger C, et al. Among authors: camuz ligios l. Heart Lung. 2022 Sep-Oct;55:134-139. doi: 10.1016/j.hrtlng.2022.05.001. Epub 2022 May 11. Heart Lung. 2022. PMID: 35567840 Free article.
Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
Kronberger C, Mousavi RA, Öztürk B, Willixhofer R, Dachs TM, Rettl R, Camuz-Ligios L, Rassoulpour N, Krall C, Litschauer B, Badr Eslam R. Kronberger C, et al. Among authors: camuz ligios l. PLoS One. 2023 Mar 9;18(3):e0282697. doi: 10.1371/journal.pone.0282697. eCollection 2023. PLoS One. 2023. PMID: 36893125 Free PMC article.
13 results